Article 9 (d)

(i)

the volume allowed for the new product is restrictive enough to prevent any material losses stemming from such new products, including, where appropriate, shorter trial periods for products referred to in Article 2, point (c);

(ii)

the authorisation is delegated separately for each type of new product and always for a limited period of time, with a maximum of 6 months;

(iii)

the authorisation, if renewed, is only renewed once by the management body;

(iv)

after a one-year period, all relevant issues referred to in point (b) are addressed, or no additional trading in that new product is allowed;